Greenwich, CTCIK 15775244 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
9 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Innoviva Inc | 2.82M | $56.29M | 25.3% | 0 | Held |
| 2 | Ironwood Pharmaceuticals Inc | 15.92M | $53.65M | 24.1% | 0 | Held |
| 3 | Neurocrine Biosciences Inc | 303.2K | $43.00M | 19.3% | 0 | Held |
| 4 |
| 396.4K |
| $25.18M |
| 11.3% |
| −192.0K |
| Reduced |
| 5 | Amarin Corp PLC | 1.67M | $23.35M | 10.5% | +430.9K | Added |
| 6 | Lantheus Hldgs Inc | 181.4K | $12.08M | 5.4% | 0 | Held |
| 7 | Biohaven Ltd | 513.2K | $5.79M | 2.6% | +513.2K | New |
| 8 | Regeneron Pharmaceuticals | 4.2K | $3.23M | 1.5% | 0 | Held |
| 9 | Vor Biopharma Inc | 25.4K | $332.2K | 0.1% | 0 | Held |